Delivery Order SPE2DB20D2104-SPE2DB25FMRTZ
Award Date
5/27/25
Potential Completion Date
5/28/25
Potential Value
$6.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DASATINIB 100 MG TABLET 30S, a prescription medication, with a ceiling value of $20,651.40 and a period of performance through June 4, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DASATINIB 100 MG TABLET 30S, a pharmaceutical product. The award has a ceiling value of $14,475.03 and a completion date of May 27, 2025. The contract is a firm-fixed price delivery order, without any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor for this award...
This federal contract award, valued at $47,839.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,956,447 tablets of the medication Dasatinib 70 mg. The contract is a firm fixed-price agreement with an ultimate completion date of April 18, 2025. This contract is not set aside for any specific business category. Amerisourcebergen Drug...
This federal contract award is for the delivery of DASATINIB 100 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a Firm Fixed Price Delivery Order with a ceiling value of $11,697.68. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,632.41, is for the delivery of the medication Dasatinib 100 mg tablets. The contract is a firm fixed-price, non-set-aside delivery order with a performance period through May 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,341.10 fixed-price delivery order is for 60 tablets of the medication Sprycel (dasatinib) 50 mg. This award does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a $80,930.59 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,713,447 units of the drug Sprycel (dasatinib) 100 mg tablets. The contract has an ultimate completion date of September 9, 2024. This contract award is not associated with a set-aside designation. As a large pharmaceutical distributor, AmerisourceBergen has been awarded numerous...
This is a $15,065.90 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Sprycel 140 mg tablets, a specialty medication, with a completion date of May 2, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a $22,631.69 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of 4,568,107,027 units of the pharmaceutical product SPRYCEL 70 MG TABLET 60S. The contract has an ultimate completion date of May 2, 2025 and is not designated as a set-aside procurement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a Delivery Order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the delivery of SPRYCEL 140 MG TABLET 30S, a specialty pharmaceutical product, with a ceiling value of $21,537.12 and a completion date of September 18, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...